The present research study focuses on the development of the highperformance thin layer chromatographic method using design of experiment approach for the simultaneous estimation of Azelastine hydrochloride and Fluticasone propionate along with forced degradation study. Methods: High performance thin layer chromatographic separation was performed on aluminium plates precoated with silica gel 60 F 254 using toluene: chloroform: methanol (5: 4: 2, v/v/v) as optimized mobile phase. Azelastine hydrochloride and Fluticasone propionate were exposed to different forced degradation conditions. Full factorial design was applied on acid and base induced degradation and statistical analysis by ANOVA was performed with interpretation of various plots. The method was validated by determination of linearity, precision, accuracy, specificity and robustness according to ICH guidelines. Results: From different forced degradation conditions, major degradation was observed in acidic and basic condition. R f for Azelastine hydrochloride and Fluticasone propionate was 0.33 and 0.53 at 232 nm. The factor, temperature showed maximum % contribution in acid and base induced degradation. Linear concentration range was 280-1680 ng/band for Azelastine hydrochloride, 100-600 ng/band for Fluticasone propionate. The % recovery ranged within 101.15-102.65% for Azelastine hydrochloride and 99.09-103.40% for Fluticasone propionate. The % R.S.D values were less than 2% for both drugs indicating that the method is accurate, sensitive and precise. Conclusion: In summary, a novel, simple, accurate and reproducible high-performance thin layer chromatographic method was developed, for routine quality control testing of pharmaceutical formulation.
INTRODUCTION
Azelastine Hydrochloride (AZH) and Fluticasone Propionate (FLU) spray is an antihistamine corticosteroid combination available as metered spray formulation for intranasal administration. AZH (Figure 1a ), a secondgeneration H₁-receptor antagonist, acts by inhibiting the release of histamine and other mediators involved in the allergic response. FLU (Figure 1b ) a highly selective agonist at the glucocorticoid receptor results in anti-inflammatory and vasoconstriction effect. Literature survey revealed that AZH and FLU are official drugs in British Pharmacopoeia 2009, 1 Indian Pharmacopoeia 2014 2 and United States Pharmacopoeia 38 National formulary 33. 3 Prior art and thorough literature survey revealed several analytical methods for the determination of FLU alone or in combinations including, UV spectrophotometry, 4,5 HPLC, [6] [7] [8] and ion pair HPLC. 10 Several methods have also been reported for the determination of AZH alone or in combinations including, UV spectrophotometry, 11 HPLC, 12 HPTLC 13 and MS-EI 14 methods. Stability indicating method is also reported for AZH using HPLC. 15 Moreover, four UV spectrophotometric methods; first order derivative, 16 double divisor ratio spectra, Ratio subtraction coupled with ratio difference and Mean centering ratio were reported for combination. 17 Only one HPLC method for the cited mixture was reported in literature. 18 However, the development of a High-performance Thin Layer Chromatographic (HPTLC) method for the simultaneous estimation of AZH and FLU in a combined dosage form has not yet been reported. Hence, this manuscript is the first to describe the development and validation of HPTLC method as per the ICH guidelines ICH Q2 (R1) for the simultaneous estimation of AZH and FLU. A multivariate approach using an experimental design was used to study the effect of simultaneously varying several factors on the responses. 19 2 3 full factorial designs were used to optimize acid and base induced degradation. A major advantage of developed HPTLC method is that several samples can be run simultaneously using a small quantity of mobile phase unlike HPLC, thus lowering the analysis time, sample clean up and cost per analysis. 20
MATERIALS AND METHODS

Materials
Analytical pure samples of AZH and FLU were gifted as a gratis sample from Zydus Cadila Healthcare Limited, Ahmedabad, Gujarat, India. These samples were used without further purification. Nasal spray formulation, "DUONASE" (Cipla Ltd, Sikkim), was purchased from the local market containing AZH (140 mcg) and FLU (50 mcg) per spray. All solvents and chemicals used were of analytical grade and purchased from S.D. Fine Chem. Ltd., Mumbai and Merck, Mumbai.
Instrumentation
A Hamilton microlitre syringe (Linomat syringe659.0014, Hamilton-Bonaduz Schweiz, Camag, Switzerland), silica gel 60 F 254 , (10 × 10 cm, 100 µm thickness; E. Merck, Darmstadt, Germany), Linomat 5 sample applicator (Camag, Switzerland), twin trough chamber (20 × 10 cm; Camag, Switzerland), TLC UV cabinet (Camag, Switzerland) and a TLC scanner 4 (Camag, Switzerland) operated by the WinCATS software (version 1.4.6, Camag, Switzerland) was used for research work. All drugs and chemicals were weighed on an electronic balance (AUW 220, Shimadzu, Japan).
Preparation of standard solutions
A stock solution of AZH and FLU was prepared by weighing accurately 10 mg of drug followed by dissolution in methanol in 10 ml volumetric flask and diluted up to the mark with methanol, to obtain a concentration of 1000 μg/ml. This stock solution was appropriately diluted to make working standard solution as and when necessary.
Chromatographic development procedure
The samples were spotted in the form of bands having band width 8 mm with a microlitre micro syringe (Linomat syringe 659.0014, Hamilton-Bonaduz Schweiz, Camag, Switzerland) on precoated silica gel aluminium HPTLC plate 60 F 254 , (10 cm ×10 cm), 100 μm thickness; (E. Merck, Darmstadt, Germany) using a Camag Linomat V sample applicator (Switzerland). Linear ascending development was carried out in 20 × 10 cm twin trough glass chamber (Camag, Switzerland). The mobile phase consisted of toluene: chloroform: methanol (5:4:2 v/v/v). The optimized chamber saturation time before chromatographic development was 20 min at room temperature (25°C ± 2). The length of chromatographic run was 8 cm which took average 15 min to develop. Subsequent to the development; TLC plates were dried in a current of air with the help of an air dryer. Densitometry scanning was performed using Camag TLC scanner IV with WinCATS software (V 1.4.6.2002, Camag). All measurements were made in the reflectance-absorbance mode at 232 nm, slit dimension (6.00 x 0.30 mm, micro), scanning speed 20 mm/s, data resolution 100μm/step, optical filter (second order), filter factor (Savitsky golay 7). The source of radiation was deuterium lamp emitting a continuous UV spectrum between 190 and 400 nm.
Forced degradation studies
To evaluate the stability indicating property of the developed HPTLC method, standard drugs were subjected to forced degradation conditions like acid/base hydrolysis, oxidation and photo degradation. In all degradation studies, area % of AZH and FLU and degradation product was considered and used for calculation.
Acid-induced degradation study
10 mg of AZH and FLU accurately weighed was transferred to 10 ml volumetric flask individually and dissolved in 3 ml methanol and diluted up to mark with hydrochloric acid (0.1 M, 0.2 M and 0.5 M separately) to obtain final concentration of 1000 μg/ml. The solutions were refluxed at 60°C and 70°C for 30 min. Neutralized samples were directly applied to HPTLC plates and the chromatograms were run under optimized chromatographic conditions.
Base-induced degradation study
In base-induced degradation study, 10 mg of AZH and FLU accurately weighed was transferred to 10 ml volumetric flask individually and dissolved in 3 ml methanol and diluted up to mark with sodium hydroxide (0.1 M, 0.2 M and 0.5 M separately) to obtain final concentration of 1000 μg/ml. The solutions were refluxed at 60°C and 70°C for 30 min. Neutralized samples were directly applied to HPTLC plates and the chromatograms were run under optimized chromatographic conditions.
Hydrogen peroxide-induced degradation study
Hydrogen peroxide induced degradation was performed by accurately weighing 10 mg of AZH and FLU, transferred to 10 ml volumetric flask individually and diluted up to the mark with hydrogen peroxide (0.3 %v/v and 3 %v/v separately) to obtain final concentration of 1000 μg/ml. The resulting solutions were directly applied to HPTLC plates and the chromatograms were developed under optimized chromatographic conditions.
Photo-degradation study
For the photo-degradation study, the AZH and FLU standard powder (10 mg) was exposed to UV light (in UV chamber) and sunlight for 24 h. After that, appropriate dilutions were made in methanol to obtain final concentration of 1000 μg/ml and then analyzed under optimized chromatographic conditions.
3 Full factorial Design for acid and base induced degradation
Full Factorial design (FFD) (2 3 ) with 8 experimental runs included 3 variables study at 2 levels. It was selected for forced degradation study. Among all degradation conditions, both the drugs in preliminary study showed more degradation under acidic and basic conditions and hence FFD was applied for studying acidic and basic degradation of both drugs. Independent variables selected were strength of acid/ base, temperature and time while % degradation of both drugs was selected as dependent variables. This choice was facilitated by the initial experiments. Factorial design and multiple regression equation were used to identify conditions for desired 0-25 % degradation. 0.5 mg/ml of AZH and FLU in (A) hydrochloric acid was refluxed using different concentration at (B) different temperature (°C) for (C) different time duration (min). Two levels were chosen for each of A, B and C.
The high level (+1) for A, B and C was 0.2 M, 70°C and 30 min respectively and low level (-1) for A, B and C was 0.1 M, 60°C and 15 min respectively (Table 1) . Similarly 0.5 mg/ml of AZH and FLU in Sodium hydroxide was refluxed using different (A) concentration at (B) different temperature (°C) for (C) different time duration (min). Two levels were chosen for each of A, B and C. The high level (+1) for A, B and C was 0.5 M, 70°C and 30 min respectively and low level (-1) for A, B and C was 0.2 M, 60°C and 15 min respectively.
Analysis of marketed formulation
To determine the concentration of AZH and FLU in nasal spray formulation (label claim: 140 and 50 μg per spray), 2.8 ml (2800 μg of AZH and 1000 μg of FLU) was taken and transferred to 100 ml beaker containing methanol and sonicated for 15 min. The solution was filtered through Whatman filter paper (0.45 μ). This solution was transferred to 10 ml volumetric flask and diluted up to mark to give a solution containing 280 μg/ ml of AZH and 100 μg/ml of FLU. Two microlitre of the filtered solution (560 ng/band of AZH and 200 ng/ band of FLU) was applied on the TLC plate followed by development and scanning. Analysis was repeated in triplicate.
Method validation
The method was validated in accordance with ICH guidelines Q2 (R1) for the evaluation of various parameters; linearity, precision, accuracy, LOD, LOQ, specificity and robustness. 11 Linear relationship between peak area and concentration of AZH and FLU were evaluated over the concentration range expressed in ng/band by making five replicate measurements in the concentration range of 280 -1680 ng/band for AZH and 100 -600 ng/band for FLU. Calibration plots were constructed by plotting the area of the peak versus the concentration of AZH and FLU using the method of ordinary least squares regression analysis. The linearity was further confirmed by Bartlett's test, to evaluate the homoscedasticity of variance. Precision of the developed method was evaluated by performing repeatability and intermediate precision studies. Repeatability on the same day was carried out by performing three replicates of three different concentration (560, 1120 and 1680 ng of AZH and 200, 400, 600 ng of FLU) and precision was expressed in terms of percent relative standard deviation (%RSD). The intermediate precision was assessed by studying three different concentrations for three different days. The accuracy of method was ascertained by performing recovery at three levels (50%, 100% and 150%). Recovery studies were carried out by spiking three different amounts of AZH standard (280, 560 and 840 ng) to the dosage form (560 ng/band) by standard addition method. Similarly, recovery studies were carried out by spiking three different amount of FLU standard (100, 200 and 300 ng) to the dosage form (200 ng/band) by standard addition method. Recovery studies were performed in triplicate. As per ICH guideline, limit of detection and quantification of the developed method was calculated from the standard deviation of the y-intercept and slope of the calibration curve of AZH and FLU using the formula, Limit of detection = 3.3*σ/S. Limit of quantitation = 10*σ/S. Where, "σ" is SD of intercept "S" is Slope of calibration curve. The specificity of the method was ascertained by comparing peak purity of standard drug with formulation and degradation sample. The spot for AZH and FLU in sample and degradation studies was confirmed by comparing the R f values and spectra of the sample spot with that of standard. Moreover, peak purity of AZH and FLU was assessed by comparing the spectra at three different levels, i.e., peak start(S), peak apex (M) and peak end (E) of the spot. As defined by the ICH, the robustness of an analytical procedure refers to its capability to remain unaffected by small and deliberate variations in method parameters. 1) Mobile phase ratio (2 ± 0.1 ml for one component), 2) Saturation time (20 ± 2 min), 3) Distance travelled (8 cm ± 2 mm), 4) Wavelength change (232 ± 2 nm) and the impact of small change was studied in terms of change in R f and peak area and expressed as %RSD.
RESULTS AND DISCUSSION
Both drugs appreciably absorbed at 232 nm and this wavelength was selected as the detection wavelength ( Figure 2 ). The optimized mobile phase (toluene: chloroform: methanol in 5:4:2 ratios resulted in good resolution with R f 0.39 for AZH and R f 0.55 for FLU ( Figure 3 ).
Forced degradation study
The results of the forced degradation study of AZH and FLU using Toluene: chloroform: methanol [5:4:2, v/v/v] as the mobile phase system are summarized in Table 1 .
Acid-induced degradation study
AZH and FLU both were found to undergo acid degradation very rapidly. The reaction in 0.5 M HCl at 70°C under reflux for 30 min showed extensive degradation for AZH with additional peaks at R f of 0.11, 0.17, 0.37, 0.49, 0.54, 0.58 respectively. For FLU, additional peaks were observed at R f of 0.31, 0.73 respectively (Figure 4 ).
Base-induced degradation study
In base-induced degradation study, AZH and FLU showed additional peaks at R f values 0.12, 0.69, 0.82, 0.93and 0.13, 0.46, 0.48, 0.52, 0.89 respectively ( Figure  5 ).
Oxidative induced degradation study
In the oxidative degradation study, it was found that both drugs were extremely liable to degradation. AZH exhibited degradation peaks at R f values 0.13, 0.35, 0.71 and 0.72 respectively and for FLU at R f values 0.10, 0.25 respectively. The densitogram for the oxidative degradation study is shown in Figure 6 .
Photo-degradation study
AZH and FLU both showed additional peaks at R f value 0.22, 0.45 and 0.34, 0.38 respectively, in the sun light ( Figure 7) . And at R f value 0.51, 0.55 and 0.35 respectively, in UV light (Figure 8 ).
3 Full factorial design for acid and base induced degradation
AZH and FLU were found to undergo acid and base induced degradation. The forced degradation experiments set up on the basis of factorial design were performed and the resulting samples were analyzed by HPTLC. Substantial degradation was observed in acidic and basic conditions. The experimental conditions and % degradation obtained for acid and base induced deg- radation is as summarized in Table 2 and Table 3 respectively. Pareto chart revealed that amongst all three factors, temperature had significant impact on % degradation of AZH and FLU, considering other variables. Pareto chart is used to estimate the importance of variable, Critical t-value, at α = 0.05 and 3 degrees of freedom were found to be 2.77645 for both responses. All factors whose absolute values of standardized effects above critical t -value are statistically significant. Pareto charts reveal that temperature and concentration showed significant impact on % degradation of AZH and % degradation of FLU (Figure 9 and Figure 11 ). Perturbation plots were constructed to evaluate the effect of the factors on the % degradation of both drugs. These graphs give the idea about how the response changes as each factor moves from its defined reference value, with all other factors held constant. Temperature (B) shows higher deviation from reference point compared to factor concentration (A) and time (C) for % degradation of both the drugs in both acidic and basic conditions (Figure 10 and 12) . The model was also validated with an Analysis of Variance (ANOVA) using the Design Expert software, (Table 4 ). Significant effects had a P value less than 0.05. An adequate precision, a measure of the signal (response) to noise ratio, greater than 4 is desirable and the obtained ratio for both drugs indicated an adequate signal. 19, 20 A coefficient of variation (% CV), which measures the reproducibility of the model, was less than 10% and the adjusted R-square values were high, indicating a good relationship between the experimental data and those of the fitted models. Here, the adjusted R 2 values were well within the acceptable limit of R 2 ≥ 0.80, which indicated that the experimental data fitted polynomial equations well. [21] [22] [23] The final equation, in terms of the actual components and factors, is as shown in Table 4 . A positive value represents an effect that favors optimization, whereas a negative value indicates an inverse relationship between the factor and the response.
Method validation
AZH and FLU showed good correlation over a concentration range of 280-1680 ng/band and 100-600 ng/band respectively with respect to peak area. The linearity of calibration curve and adherence of system to Beer's law was evaluated by high value of correlation coefficient ( Figure 13 and Table 5 ).
The precision of developed method was evaluated by repeatability and intermediate precision and was expressed as %RSD of peak area. Repeatability and intermediate precision was at three different concentrations (Table 5) , indicating acceptable precision in terms of repeatability of peak area measurement and sample application. The proposed method when used for evaluation of recovery at three concentrations levels, 50%, 100% and 150% after spiking with standard, showed percentage recovery between 101.15-102.65%
for AZH and 99.09-103.40% for FLU ( Table 5 ). Limit of detection and limit of quantitation were found to be, for AZH; 12.657 ng/band and 38.354 ng/band, for FLU; 3.260 ng/band and 9.880 ng/band, indicating good sensitivity of the method ( Table 5 ). The marketed formulation using the developed method, showed only one peak at R f of 0.33 and 0.52 for AZH and FLU that were found to be at the same R f for standard by the peak purity of AZH and FLU in marketed formulations comparing the spectra at peak start, peak apex and peak end positions of the spot, showed good correlation i.e., r (S, M) = 0.9997 and r (M, E) = 0.9998 for AZH and r (S, M) = 0.9992 and r (M, E) = 0.9996 for FLU ( Figure 14) . Similarly, the peak purity of AZH and FLU in degradation samples comparing the spectra at peak start, peak apex and peak end positions of the spot, showed good correlation i.e., r (S, M) = 0.9994 and r (M, E) = 0.9998 for AZH and r (S, M) = 0.9997 and r (M, E) = 0.9998 for FLU ( Table 5 ). The degradation sample also showed only one peak at R f of 0.34 and 0.55 for AZH and FLU ( Figure 15 ). Deliberate change in different parameters like mobile phase composition, saturation time, distance travel, wavelength scan, showed % relative standard deviation of peak area less than 2%, indicates that the method is robust (Table 6 ). Results presented in Table 6 indicate that the selected factors remained unaffected by small variation of these parameters.
Analysis of pharmaceutical formulation
The nasal spray formulation using the developed method, showed separate peak at R f 0.32 for AZH and 0.58 for FLU indicating no interference of the excipient and showed mean %recovery of 105.2 ± 1.27 and 96.02 ± 1.19 for AZH and FLU respectively. (Figure 16 ).
CONCLUSION
HPTLC method using DoE approach was developed and validated for the determination of AZH and FLU. The developed method was found to be simple, rapid, specific, sensitive and suitable for the determination of AZH and FLU. The proposed method was applied for the analysis of AZH and FLU in nasal spray formulation. Additional advantages include high sample throughput, short system equilibration time, minimum mobile phase requirement and no prior requirement of degassing and filtration of mobile phase. Acid-induced degradation resulted in 40.66% degradation of AZH and 24.77% of FLU with 0.5 M HCl at 70°C for 30 min. Similarly, base induced degradation resulted in 26.33% degradation of AZH and 18.06% degradation of FLU with 0.5 M NaOH at 70°C for 30 min. Moreover, in oxidative and photolytic conditions, degradation was less. Forced degradation study showed that all degradation products were well separated from AZH and FLU, hence the method can be employed individually for forced degradation study for both drugs. 
